医学
观察研究
内科学
系统性红斑狼疮
皮肤病科
重症监护医学
疾病
作者
Ruilin Chen,Rong Fu,Zeying Lin,Chenghui Huang,Wenhui Huang
出处
期刊:Lupus
[SAGE Publishing]
日期:2022-11-23
卷期号:32 (1): 94-100
被引量:47
标识
DOI:10.1177/09612033221141253
摘要
Telitacicept is a potential treatment option for patients with SLE, especially in lupus nephritis, with significantly increased SRI-4 response rate and reduced the glucocorticoid and immunosuppressive drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI